Contact A Lawyer
Have A Potential Case Reviewed By An Attorney
The hypertension drug Benicar has been linked to cases of sprue-like enteropathy, which causes chronic diarrhea, weight gain and other serious gastrointestinal problems.
BENICAR LAWSUIT STATUS: In July 2017, the makers of Benicar agreed to settle litigation over gastrointestinal injuries for about $300 million. As a result of the drug maker’s failure to properly warn about risks associated with the medication, Benicar lawsuits are being pursued by lawyers on behalf of former users who have suffered:
- Chronic Diarrhea Resulting in Hospitalization
- Sprue-Like Enteropathy
- Celiac Disease Misdiagnosis
- Chronic Malnourishment, Dehydration and Stomach Problems
MANUFACTURERS: Daiichi Sankyo, Inc. and Forest Laboratories
OVERVIEW: Benicar (olmesartan medoxomil) is a hypertension drug that belongs to a class of medications known as angiotensin II receptor blockers (ARBs). A family of drugs containing the same pharmaceutical ingredient have been developed by Daiich Sankyo, including Benicar HCT, Azor, and Tribenzor.
An estimated 1.9 million people received prescriptions for Benicar or a related drug in 2012, and about 10.6 million prescriptions for Benicar products were dispensed altogether that year. It is the third highest selling ARB blood pressure medication on the market.
Recent studies have suggested that there is a link between side effects of Benicar and chronic diarrhea, which may have gone undiagnosed in patients for years. In many cases, these stomach problems were misdiagnosed as Celiac disease, which may actually be related to Benicar enteropathy.
BENICAR DIARRHEA SIDE EFFECTS: In July 2013, the FDA issued a drug safety warning indicating that Benicar may cause sprue-like enteropathy, resulting in symptoms like chronic diarrhea, weight loss and other gastrointestinal problems.
The drug regulatory agency indicated that at least 23 cases of diarrhea from Benicar were identified among adverse event reports submitted by users of the drug, where symptoms improved after use of the medication was discontinued. In 10 of the cases, symptoms returned against when the medication was resumed. This led the FDA to indicate that there is “clear evidence” of an association between Benicar and enteropathy.
In August 2012, a report was published by the Mayo Clinic highlighting a number of cases involving symptoms consistent with Celiac disease after taking Benicar. At least 22 cases of long-lasting diarrhea were identified among patients treated at clinics in 17 different states, where signs of improvement were seen after Benicar was stopped. Among the reports reviewed:
- 100% experienced chronic diarrhea lasting 3 to 53 months
- 100% experienced weight loss between 5 and 110 pounds
- 68% experienced nausea and vomiting
- 50% experienced abdominal pain
- 41% experienced bloating
- 68% experienced fatigue
BENICAR SPRUE-LIKE ENTEROPATHY LAWSUITS: Benicar lawyers are reviewing potential lawsuits for individuals throughout the United States as a result of Daiichi Sankyo and Forest Laboratories’ failure to provide adequate warnings fur users or the medical community. To review a potential claim for yourself, a friend or family member, request a free consultation and claim evaluation.